In the present study, we explored the associations of serum CCL21 and CCR7 levels with the risk of Hashimoto’s thyroiditis and evaluated differences in the expression of serum CCL21 and CCR7 in patients with different thyroid antibodies and thyroid function status. This evidence concerns the gene CCL21 and Hashimoto thyroiditis.